NCT05521087 2025-06-22A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasJanssen Research & Development, LLCPhase 1 Withdrawn
NCT04752163 2025-05-23DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Terminated17 enrolled 15 charts